According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current number of shares outstanding is 188,219,000. At the end of 2023 the company had 188,219,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.18 B | 1.18% |
2022 | 0.18 B | 1.35% |
2021 | 0.18 B | 1.17% |
2020 | 0.18 B | 1.06% |
2019 | 0.17 B | 0.9% |
2018 | 0.17 B | 1.4% |
2017 | 0.17 B | 2.02% |
2016 | 0.17 B | 6.74% |
2015 | 0.16 B | 8.74% |
2014 | 0.14 B | 5.26% |
2013 | 0.14 B | 13.02% |
2012 | 0.12 B | 10.94% |
2011 | 0.11 B | 9.97% |
2010 | 0.10 B | 1.77% |
2009 | 0.10 B | 0.8% |
2008 | 99.53 M | 3.47% |
2007 | 96.19 M | 11.51% |
2006 | 86.26 M | 19.82% |
2005 | 71.99 M | 11.82% |
2004 | 64.38 M | 0.89% |
2003 | 63.81 M | 19.4% |
2002 | 53.44 M | 26.84% |
2001 | 42.13 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Sanofi SNY | 2,507,200,000 | 1,232.07% | ๐ซ๐ท France |
Ultragenyx RARE | 71,664,493 | -61.92% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | 177,171,000 | -5.87% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | 111,869,478 | -40.56% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | 295,759,435 | 57.14% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | 106,568,137 | -43.38% | ๐บ๐ธ USA |